
|Articles|October 15, 2003
Ocular inflammation approach raises glaucoma risk
Birmingham, AL-Glaucoma can arise as a complication of uveitis or as a result of steroids used to treat the inflammatory disorder, said Christopher A. Girkin, MD, associate professor of ophthalmology and director of the glaucoma service, University of Alabama, Birmingham. He reviewed information on the epidemiology, mechanisms, and management of inflammatory and steroid-induced glaucoma.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
5















































.png)


